Drug Type Small molecule drug |
Synonyms MC-1/lisinopril + [1] |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), Purinergic P2 receptor antagonists |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC29H43N4O12P |
InChIKeyREBBBJFPEGDMGO-ZUIPZQNBSA-N |
CAS Registry930587-75-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myocardial Ischemia | Phase 3 | CA | 01 Nov 2006 | |
Reperfusion Injury | Phase 3 | US | 01 Nov 2006 | |
Reperfusion Injury | Phase 3 | CA | 01 Nov 2006 | |
Diabetes Mellitus | Phase 3 | - | - | |
Hypertension | Phase 3 | - | - | |
Myocardial Ischemia | Discovery | US | 01 Nov 2006 |